Drugs similar to or like CVnCoV

COVID-19 vaccine candidate developed by CureVac AG and the Coalition for Epidemic Preparedness Innovations . Wikipedia

  • COVID-19 vaccine candidate developed by Novavax and Coalition for Epidemic Preparedness Innovations (CEPI). Stable at 2 to 8 C . Wikipedia

  • Global initiative aimed at equitable access to COVID-19 vaccines led by the Global Alliance for Vaccines and Immunization , the World Health Organization (WHO), the Coalition for Epidemic Preparedness Innovations (CEPI), and others. One of the three pillars of the Access to COVID-19 Tools Accelerator, an initiative begun in April 2020 by the World Health Organization , the European Commission, and the government of France as a response to the COVID-19 pandemic. Wikipedia

  • COVID-19 vaccine candidate developed by Valneva SE. Undergoing a Phase 1/2 trial in the United Kingdom. Wikipedia

  • COVID-19 vaccine candidate developed by Medicago and GlaxoSmithKline . Coronavirus virus-like particle vaccine grown in the Australian weed, Nicotiana benthamiana. Wikipedia

  • COVID-19 vaccine candidate developed by the University of Queensland and the Australian pharmaceutical company CSL Limited. The vaccine candidate used the University of Queensland's molecular clamp technology, and the MF59 adjuvant. Wikipedia

  • CoronaVac

    Inactivated virus COVID-19 vaccine developed by Sinovac. It has been in Phase III clinical trials in Brazil, Chile, Indonesia, Philippines, and Turkey. Wikipedia

  • Vice chair of the Coalition for Epidemic Preparedness Innovations (CEPI). Robinson manages the CEPI manufacturing strategy for a COVID-19 vaccine. Wikipedia

  • Pfizer–BioNTech COVID-19 vaccine

    COVID-19 vaccine developed by the German company BioNTech in cooperation with Pfizer. Both the first COVID-19 vaccine to be authorized by a stringent regulatory authority for emergency use and the first cleared for regular use. Wikipedia

  • Coalition for Epidemic Preparedness Innovations

    Foundation that takes donations from public, private, philanthropic, and civil society organisations, to finance independent research projects to develop vaccines against emerging infectious diseases (EID). Focused on the World Health Organization's "blueprint priority diseases", which include: the Middle East respiratory syndrome-related coronavirus (MERS-CoV), the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the Nipah virus, the Lassa fever virus, and the Rift Valley fever virus, as well as the Chikungunya virus and the hypothetical, unknown pathogen "Disease X". Wikipedia

  • Moderna COVID-19 vaccine

    COVID-19 vaccine developed by the United States National Institute of Allergy and Infectious Diseases , the Biomedical Advanced Research and Development Authority (BARDA), and Moderna. Administered by two 0.5 mL doses given by intramuscular injection given four weeks apart. Wikipedia

  • COVID-19 vaccine developed by the Vector Institute. The EpiVacCorona vaccine contains fragments extracted from the virus synthetic peptide antigens. Wikipedia

  • Oxford–AstraZeneca COVID-19 vaccine

    COVID-19 vaccine developed by Oxford University and AstraZeneca given by intramuscular injection, using as a vector the modified chimpanzee adenovirus ChAdOx1. Followed by a full-dose after at least one month, based on mixed trials with no participants over 55 years old. Wikipedia

  • One of two inactivated virus COVID-19 vaccines developed by Sinopharm. In Phase III trials in Argentina, Bahrain, Egypt, Morocco, Pakistan, Peru, and the United Arab Emirates with over 60,000 participants. Wikipedia

  • Adjuvanted protein subunit COVID-19 vaccine candidate developed by Anhui Zhifei Longcom in collaboration with the Institute of Microbiology at the Chinese Academy of Sciences. In Phase III trials with 29,000 participants in China, Ecuador, Malaysia, Pakistan, and Uzbekistan. Wikipedia

  • G20 initiative announced by pro-tem Chair Mohammed al-Jadaan on 24 April 2020. Published simultaneously by the World Health Organization on 24 April. Wikipedia

  • Single-dose viral vector COVID-19 vaccine developed by CanSino Biologics. Since late 2020, it has been in Phase III trials in Argentina, Chile, Mexico, Pakistan, Russia, and Saudi Arabia with 40,000 participants. Wikipedia

  • COVID-19 vaccine candidate developed by Iranian state-owned Shifa Pharmed Industrial Group. It has successfully been tested on animals and has been approved by the Iran Food and Drug Administration for testing on humans. Wikipedia

  • COVID-19 vaccine candidate produced by the Finlay Institute, a Cuban epidemiological research institute. Conjugate vaccine. Wikipedia

  • COVID-19 vaccine candidate developed by Janssen Vaccines, which is part of Johnson & Johnson in the Netherlands and Beth Israel Deaconess Medical Center (BIDMC). Human adenovirus viral vector vaccine. Wikipedia

  • Inactivated virus based COVID-19 vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research. In May 2020, Indian Council of Medical Research's (ICMR's) National Institute of Virology approved and provided the virus strains for developing a fully indigenous COVID-19 vaccine. Wikipedia

  • Sputnik V COVID-19 vaccine

    COVID-19 vaccine developed by the Gamaleya Research Institute of Epidemiology and Microbiology, and registered on 11 August 2020 by the Russian Ministry of Health as Gam-COVID-Vac (Гам-КОВИД-Вак). Adenovirus viral vector vaccine. Wikipedia

  • Operation Warp Speed

    Public–private partnership initiated by the U.S. government to facilitate and accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics. On April 29, 2020, and the program was officially announced on May 15, 2020. Wikipedia

  • History of COVID-19 vaccine development

    Isolated in December 2019, its genetic sequence was published on 11 January 2020, triggering an urgent international response to prepare for an outbreak and hasten development of a preventive COVID-19 vaccine. Since early 2020, vaccine development has been expedited via unprecedented collaboration in the multinational pharmaceutical industry and between governments. Wikipedia

  • Deployment of COVID-19 vaccines

    As of 19 February 2021, 200.33 million COVID‑19 vaccine doses had been administered worldwide based on official reports from national health agencies collated by Our World in Data. During a pandemic on the rapid timeline and scale of COVID‑19 infections during 2020, international organizations like the WHO and CEPI, vaccine developers, governments, and industry are evaluating the distribution of the eventual vaccine(s). Wikipedia

  • COVID-19 vaccine

    [[File:COVID-19 vaccine map.svg|thumb|upright=1.2|Map of countries by approval status ]] Wikipedia

  • List of vaccine topics

    List of vaccine-related topics. Biological preparation that improves immunity to a particular disease. Wikipedia

  • COVID-19 vaccination in the United Kingdom

    World's first mass immunisation campaign to protect against SARS-CoV-2 using vaccines developed in response to the COVID-19 pandemic. RNA vaccine. Wikipedia

  • RNA vaccine

    Type of vaccine that uses a copy of a natural chemical called messenger RNA (mRNA) to produce an immune response. The vaccine transfects molecules of synthetic RNA into immunity cells. Wikipedia

  • COVID-19 pandemic in Belgium

    Part of the ongoing worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Confirmed to have spread to Belgium on 4 February 2020, when one of a group of nine Belgians repatriated from Wuhan to Brussels was reported to have tested positive for the coronavirus. Wikipedia

  • COVID-19 pandemic in the United Kingdom

    Part of the worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus reached the country in late January 2020. Wikipedia

Sentences

Sentences forCVnCoV

This will create an email alert.  Stay up to date on result for: CVnCoV